Structure Therapeutics, Inc. (GPCR)
35.00
-0.10
(-0.28%)
USD |
NASDAQ |
Sep 18, 16:00
35.11
+0.11
(+0.31%)
After-Hours: 20:00
Structure Therapeutics Price to Book Value : 1.840 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.840 |
| September 17, 2026 | 1.846 |
| September 16, 2026 | 1.867 |
| September 15, 2026 | 2.048 |
| September 14, 2026 | 2.021 |
| September 11, 2026 | 2.033 |
| September 10, 2026 | 2.080 |
| September 09, 2026 | 2.168 |
| September 08, 2026 | 2.123 |
| September 04, 2026 | 2.489 |
| September 03, 2026 | 2.489 |
| September 02, 2026 | 2.513 |
| September 01, 2026 | 2.478 |
| August 31, 2026 | 2.414 |
| August 28, 2026 | 2.491 |
| August 27, 2026 | 2.588 |
| August 26, 2026 | 2.595 |
| August 25, 2026 | 2.625 |
| August 24, 2026 | 2.577 |
| August 21, 2026 | 2.581 |
| August 20, 2026 | 2.656 |
| August 19, 2026 | 2.846 |
| August 18, 2026 | 2.815 |
| August 17, 2026 | 2.827 |
| August 14, 2026 | 2.866 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.876 |
| August 12, 2026 | 2.835 |
| August 11, 2026 | 2.741 |
| August 10, 2026 | 2.829 |
| August 07, 2026 | 2.794 |
| August 06, 2026 | 2.767 |
| August 05, 2026 | 2.657 |
| August 04, 2026 | 2.610 |
| August 03, 2026 | 2.543 |
| July 31, 2026 | 2.526 |
| July 30, 2026 | 2.601 |
| July 29, 2026 | 2.490 |
| July 28, 2026 | 2.518 |
| July 27, 2026 | 2.560 |
| July 24, 2026 | 2.583 |
| July 23, 2026 | 2.671 |
| July 22, 2026 | 2.651 |
| July 21, 2026 | 2.595 |
| July 20, 2026 | 2.470 |
| July 17, 2026 | 2.549 |
| July 16, 2026 | 2.420 |
| July 15, 2026 | 2.609 |
| July 14, 2026 | 2.660 |
| July 13, 2026 | 2.715 |
| July 10, 2026 | 2.806 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.04 |
| Novo Nordisk A/S | 5.648 |
| Pfizer Inc. | 1.850 |
| Johnson & Johnson | 7.652 |
| Merck & Co., Inc. | 8.646 |
Price to Book Value Related Metrics
| Price | 35.00 |
| Earnings Yield | -8.80% |
| Market Cap | 2.493B |